FOUNDATIONS OF COST-EFFECTIVENESS ANALYSIS FOR HEALTH AND MEDICAL PRACTICES

被引：1492

作者：

WEINSTEIN, MC ^{[1
]}

STASON, WB ^{[1
]}

机构：

[1] HARVARD UNIV,CTR ANAL HLTH PRACTICES,SCH MED,BOSTON,MA 02115

来源：

关键词：

D O I：

10.1056/NEJM197703312961304

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：716 / 721

页数：6

共 23 条

[1] ACTON JP, 1973, R950RC RAND CORP REP
[2] ACTON JP, 1975, R1697NHLI RAND CORP
[3] Bunker J.P., 1974, BENEFITS RISKS MEDIC, P85
[4] BUNKER JP, 1977, COSTS RISKS BENEFITS
[5] Bush J.W., 1973, HLTH STATUS INDEXES
[6] Chase S.B, 1968, PROBLEMS PUBLIC EXPE, P127, DOI DOI 10.1037/12069-015
[7] PROTECTING MEDICAL COMMONS - WHO IS RESPONSIBLE
HIATT, HH
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (05) : 235 - 241
[8] Klarman H.E., 1965, MEASURING BENEFITS G, P367
[9] KLARMAN HE, 1973, HSM733016 DHEW PUBL
[10] MEASURES OF CLINICAL EFFICACY - COST-EFFECTIVENESS CALCULATIONS IN DIAGNOSIS AND TREATMENT OF HYPERTENSIVE RENOVASCULAR DISEASE
MCNEIL, BJ
VARADY, PD
BURROWS, BA
ADELSTEIN, SJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (05) : 216 - 221